You are here

Pharmaceutical-Approval Update: Oncology October 2003

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Dr. Goldenberg reviews bortezomib for injection (Velcade™) for multiple myeloma, gefitinib (Iressa™) for non-small cell lung cancer, and Bexxar® for non-Hodgkin’s lymphoma.